Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 23 Feb 2021 for Theravance Biopharma, Inc., €554k.
Filing timeline
BuySaleBrett K. Haumann
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Brett K. Haumann: trading record in brief
Brett K. Haumann has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Theravance Biopharma, Inc. and Aimmune Therapeutics, Inc. Over a trading history stretching from 20 February 2016 to 20 February 2021, the count stands at 37 filings.
Every open-market trade on record is a sale: 5 sales worth €1.1M. Besides market trades, the filings include 30 share grants.
The record was last updated on 23 February 2021 with a share grant (€554k) in Theravance Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brett K. Haumann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
35,672 shares@ US$18.799.5% of flowOrdinary SharesSEC:0001179110-21-002157:0
4,639 shares@ US$17.214.7% of flowOrdinary SharesSEC:0001179110-20-011367:0
6,250 shares@ US$34.5031.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028178:0
13,313 shares@ US$34.5068.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028178:1
4,646 shares@ US$18.225.0% of flowOrdinary SharesSEC:0001179110-20-009263:0
25,000 shares@ US$18.2926.9% of flowOrdinary SharesSEC:0001179110-20-009263:1
13,313 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-014618:0
4,212 shares@ US$26.676.9% of flowOrdinary SharesSEC:0001179110-20-006524:0
33,608 shares@ US$25.9052.8% of flowOrdinary SharesSEC:0001179110-20-002143:0
65,000 shares0Ordinary SharesSEC:0001179110-20-001198:0
54,000 shares0Ordinary SharesSEC:0001179110-20-001198:1
2,692 shares@ US$17.602.1% of flowOrdinary SharesSEC:0001179110-19-012013:0
2,710 shares@ US$21.512.5% of flowOrdinary SharesSEC:0001179110-19-009785:0
2,705 shares@ US$19.841.8% of flowOrdinary SharesSEC:0001179110-19-006520:0
7,778 shares@ US$27.006.5% of flowOrdinary SharesSEC:0001179110-19-002409:0
65,000 shares0Ordinary SharesSEC:0001179110-19-001558:0
47,250 shares0Ordinay SharesSEC:0001179110-19-001558:1
7,368 shares@ US$24.795.6% of flowOrdinary SharesSEC:0001179110-18-013106:0
6,683 shares@ US$26.955.2% of flowOrdinary SharesSEC:0001179110-18-010818:0
26,991 shares@ US$24.3110.6% of flowOrdinary SharesSEC:0001179110-18-007371:0
33,750 shares0Ordinary SharesSEC:0001179110-18-006935:0
8,293 shares@ US$29.093.7% of flowOrdinary SharesSEC:0001179110-18-002607:0
9,000 shares0Ordinary SharesSEC:0001179110-18-002122:0
7,846 shares@ US$28.583.6% of flowOrdinary SharesSEC:0001179110-17-014562:0
7,064 shares@ US$27.403.1% of flowOrdinary SharesSEC:0001179110-17-011747:0
25 of 37 declarations
